PGNY
Progyny, Inc. NASDAQ Listed Oct 25, 2019$26.08
-0.87%
vs $26.31
Mkt Cap $2.3B
52w Low $16.30
80.7% of range
52w High $28.42
50d MA $22.15
200d MA $22.08
P/E (TTM)
40.1x
EV/EBITDA
20.2x
P/B
4.3x
Debt/Equity
0.1x
ROE
2.4%
P/FCF
12.2x
RSI (14)
54.90
ATR (14)
$0.84
Beta
0.99
50d MA
$22.15
200d MA
$22.08
Avg Volume
1.7M
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
1359 Broadway · New York City, NY 10018 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.26 | 0.29 | +13.3% | 19.16 | +22.1% | +23.8% | -4.9% | +4.0% | +0.3% | -2.7% | — |
| Feb 26, 2026 | AMC | 0.15 | 0.15 | +2.0% | 22.25 | -10.7% | -20.5% | -0.5% | -0.5% | +1.5% | -1.0% | — |
| Nov 6, 2025 | AMC | 0.39 | 0.45 | +15.4% | 18.01 | +14.8% | +24.2% | +5.6% | +0.8% | +1.1% | +1.5% | — |
| Aug 7, 2025 | AMC | 0.44 | 0.48 | +9.1% | 23.06 | +13.7% | -0.9% | -4.8% | +0.1% | +5.9% | -2.2% | — |
| May 8, 2025 | AMC | 0.45 | 0.48 | +6.7% | 23.37 | -2.6% | -9.3% | +3.8% | -1.5% | +0.8% | +0.4% | — |
| Feb 27, 2025 | AMC | 0.37 | 0.42 | +13.5% | 22.88 | +16.0% | -1.5% | -2.4% | -2.0% | +0.6% | -3.0% | — |
| Nov 12, 2024 | AMC | 0.37 | 0.40 | +8.1% | 17.18 | -13.3% | -19.1% | +0.6% | -1.5% | +0.9% | -1.7% | — |
| Aug 6, 2024 | AMC | 0.36 | 0.43 | +19.4% | 25.74 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% | — |
| May 9, 2024 | AMC | 0.14 | 0.39 | +178.6% | 32.50 | -26.5% | -15.3% | -0.5% | +0.3% | -2.5% | +2.9% | — |
| Feb 27, 2024 | AMC | 0.11 | 0.32 | +190.9% | 40.79 | -11.3% | -15.1% | +5.4% | -1.4% | -1.5% | -2.8% | — |
| Nov 7, 2023 | AMC | 0.12 | 0.16 | +33.3% | 32.00 | +0.0% | -7.8% | +0.3% | +2.0% | +1.0% | +4.5% | — |
| Aug 3, 2023 | AMC | 0.10 | 0.15 | +50.0% | 40.43 | +3.9% | +6.1% | -4.4% | -3.0% | -1.8% | -3.2% | — |
| May 8, 2023 | AMC | 0.07 | 0.18 | +157.1% | 34.85 | +3.9% | +8.5% | -0.7% | -2.8% | +0.4% | -1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 | Canaccord Genuity | Upgrade | Hold → Buy | $30 | $24.05 | $24.46 | +1.7% | +2.3% | +4.2% | -3.7% | +0.8% | +0.7% |
| Mar 20 | Barclays | Maintains | Overweight → Overweight | — | $18.18 | $18.17 | -0.1% | -0.3% | -0.7% | +0.2% | -1.7% | +0.2% |
| Mar 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $17.91 | $17.65 | -1.5% | -2.2% | -0.1% | +0.0% | -0.5% | +3.6% |
| Mar 5 | BTIG | Maintains | Buy → Buy | — | $17.79 | $17.67 | -0.7% | -1.0% | +3.9% | -0.3% | -1.9% | -2.2% |
| Mar 2 | Truist | Maintains | Buy → Buy | — | $17.69 | $17.27 | -2.4% | -0.5% | -0.5% | +1.5% | -1.0% | +3.9% |
| Mar 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $17.69 | $17.27 | -2.4% | -0.5% | -0.5% | +1.5% | -1.0% | +3.9% |
| Jan 20 | Citizens | Upgrade | Market Perform → Market Outperform | — | $24.52 | $25.05 | +2.2% | +3.5% | +0.3% | -1.8% | +0.9% | -1.5% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.80 | $27.51 | +2.6% | +2.4% | -1.6% | +5.3% | -11.2% | +3.5% |
| Nov 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $24.55 | $25.50 | +3.9% | +9.2% | -3.6% | -1.7% | -2.2% | +4.1% |
| Nov 12 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $23.81 | $24.32 | +2.1% | +1.1% | +1.5% | +0.5% | +9.2% | -3.6% |
| Nov 11 | JP Morgan | Maintains | Neutral → Neutral | — | $23.62 | $23.79 | +0.7% | +0.8% | +1.1% | +1.5% | +0.5% | +9.2% |
| Aug 26 | JP Morgan | Maintains | Neutral → Neutral | — | $23.14 | $23.07 | -0.3% | -2.2% | +1.7% | +1.0% | +1.8% | -1.1% |
| Aug 20 | Canaccord Genuity | Maintains | Hold → Hold | — | $22.74 | $22.80 | +0.3% | -0.8% | +2.5% | +1.7% | -1.7% | -2.2% |
| Aug 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $23.06 | $26.21 | +13.7% | -0.9% | -4.8% | +0.1% | +5.9% | -2.2% |
| Jul 17 | Truist | Maintains | Hold → Hold | — | $23.02 | $23.01 | -0.0% | -0.0% | -4.4% | +4.3% | +0.2% | +2.1% |
| Jul 8 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $21.45 | $21.66 | +1.0% | +13.1% | -2.0% | -0.7% | -1.7% | +1.1% |
| May 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.19 | $21.20 | +0.0% | +3.8% | -1.5% | +0.8% | +0.4% | +1.6% |
| Mar 31 | BTIG | Upgrade | Neutral → Buy | — | $21.90 | $22.13 | +1.1% | +2.0% | +3.4% | -0.5% | +0.7% | -2.4% |
| Feb 28 | Canaccord Genuity | Maintains | Hold → Hold | — | $22.88 | $26.55 | +16.0% | -1.5% | -2.4% | -2.0% | +0.6% | -3.0% |
| Feb 11 | BofA Securities | Maintains | Buy → Buy | — | $22.35 | $22.74 | +1.7% | +0.2% | -1.7% | -0.3% | +1.9% | +1.9% |
| Jan 28 | JP Morgan | Maintains | Neutral → Neutral | — | $22.95 | $22.93 | -0.1% | +2.8% | -1.4% | +1.2% | -1.6% | +1.9% |
| Dec 2 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.57 | $15.20 | -2.4% | +0.1% | -4.7% | +0.2% | +0.8% | -1.6% |
| Nov 14 | Barclays | Maintains | Overweight → Overweight | — | $13.90 | $13.91 | +0.1% | +0.6% | -1.5% | +0.9% | -1.7% | +2.3% |
| Nov 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $17.18 | $14.90 | -13.3% | -19.1% | +0.6% | -1.5% | +0.9% | -1.7% |
| Nov 13 | Truist | Downgrade | Buy → Hold | — | $17.18 | $14.90 | -13.3% | -19.1% | +0.6% | -1.5% | +0.9% | -1.7% |
| Nov 13 | BofA Securities | Maintains | Buy → Buy | — | $17.18 | $14.90 | -13.3% | -19.1% | +0.6% | -1.5% | +0.9% | -1.7% |
| Oct 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $16.76 | $16.89 | +0.8% | -3.5% | +0.9% | -3.1% | +3.0% | -1.3% |
| Sep 20 | Canaccord Genuity | Maintains | Hold → Hold | — | $16.46 | $16.35 | -0.7% | +1.0% | +3.4% | -0.2% | -2.9% | +0.4% |
| Sep 19 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Sep 19 | Jefferies | Maintains | Buy → Buy | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Sep 19 | JP Morgan | Maintains | Overweight → Overweight | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Sep 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Sep 19 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Sep 19 | Truist | Maintains | Buy → Buy | — | $24.44 | $17.60 | -28.0% | -32.7% | +1.0% | +3.4% | -0.2% | -2.9% |
| Aug 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $21.18 | $21.14 | -0.2% | -0.6% | +2.4% | -2.5% | +3.7% | -0.5% |
| Aug 19 | JP Morgan | Maintains | Overweight → Overweight | — | $21.04 | $21.05 | +0.0% | +0.7% | -0.6% | +2.4% | -2.5% | +3.7% |
| Aug 7 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| Aug 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| Aug 7 | BTIG | Downgrade | Buy → Neutral | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| Aug 7 | Truist | Maintains | Buy → Buy | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| Aug 7 | Canaccord Genuity | Downgrade | Buy → Hold | — | $25.74 | $21.00 | -18.4% | -19.0% | +0.5% | +3.1% | -2.7% | +2.8% |
| May 17 | Truist | Maintains | Buy → Buy | — | $27.55 | $27.54 | -0.0% | +2.0% | -0.3% | -1.9% | -2.6% | +1.5% |
| May 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $26.78 | $26.81 | +0.1% | +2.9% | +2.0% | -0.3% | -1.9% | -2.6% |
| May 13 | Barclays | Maintains | Overweight → Overweight | — | $27.53 | $27.74 | +0.8% | -0.5% | +0.3% | -2.5% | +2.9% | +2.0% |
| May 10 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $32.50 | $23.90 | -26.5% | -15.3% | -0.5% | +0.3% | -2.5% | +2.9% |
| May 10 | BTIG | Maintains | Buy → Buy | — | $32.50 | $23.90 | -26.5% | -15.3% | -0.5% | +0.3% | -2.5% | +2.9% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.50 | $23.90 | -26.5% | -15.3% | -0.5% | +0.3% | -2.5% | +2.9% |
| Apr 17 | Truist | Maintains | Buy → Buy | — | $33.39 | $33.62 | +0.7% | -1.9% | -2.7% | +2.6% | +1.1% | -2.0% |
| Feb 28 | Truist | Maintains | Buy → Buy | — | $40.79 | $36.18 | -11.3% | -15.1% | +5.4% | -1.4% | -1.5% | -2.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Clapp GeoffreyOff | Chief Product Officer | Sell | 1,530 | $25.58 | $39K | 59,117 | +1.96% | +0.23% |
| Jun 2, 2026 | Livingston Mark S.Off | CHIEF FINANCIAL OFFICER | Sell | 279 | $26.20 | $7K | 78,626 | +1.96% | +0.23% |
| Jun 1, 2026 | Scott CherylDir | — | Sell | 7,439 | $26.39 | $196K | 19,772 | +1.96% | +0.23% |
| May 28, 2026 | Swartz AllisonOff | EVP, GC | Sell | 2,398 | $25.46 | $61K | 85,191 | -4.12% | +0.23% |
| May 20, 2026 | Livingston Mark S.Off | CHIEF FINANCIAL OFFICER | Sell | 8,275 | $25.50 | $211K | 79,063 | +0.77% | -0.51% |
| May 19, 2026 | Cummings Melissa BOff | Chief Operating Officer | Sell | 9,578 | $25.00 | $239K | 73,371 | +0.77% | -0.51% |
8-K · 5.03
! Medium
Progyny, Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
Progyny changed its fiscal year end, which may affect earnings reporting schedules and investor expectations for future quarterly and annual financial disclosures.
May 27
8-K · 8.01
!! High
Progyny, Inc. -- 8-K 8.01: Material Event / Announcement
Progyny announced a share repurchase program funded by cash reserves, allowing flexibility to buy back stock in open market transactions based on price and market conditions.
May 26
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Progyny faces shareholder litigation settlement that could provide legal closure and reduce future liability exposure, though settlement terms remain undisclosed pending court approval.
Mar 13
8-K · 7.01
! Medium
Progyny, Inc. -- 8-K 7.01: Regulation FD Disclosure
Progyny disclosed earnings results and supplemental presentation materials via 8-K filing, providing investors with detailed financial performance information and forward-looking guidance on its investor relations website.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 6,500,819 | $110M | Reduced | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 5,292,028 | $90M | New | Mar 2026 |
| 3 | Morgan Stanley | 2,573,262 | $66M | Added | Dec 2025 |
| 4 | Vanguard Capital Management Llc | 3,481,339 | $59M | New | Mar 2026 |
| 5 | Fort Washington Investment Advisors Inc /oh/ | 2,693,393 | $46M | Added | Mar 2026 |
| 6 | Soleus Capital Management, L.p. | 2,067,000 | $35M | New | Mar 2026 |
| 7 | Bank Of America Corp /de/ | 1,190,996 | $20M | Added | Mar 2026 |
| 8 | Qube Research & Technologies Ltd | 574,565 | $15M | Added | Mar 2026 |
| 9 | Easterly Investment Partners Llc | 833,448 | $14M | Added | Mar 2026 |
| 10 | Northern Trust Corp | 818,176 | $14M | Added | Mar 2026 |
| 11 | Renaissance Technologies Llc | 812,067 | $14M | Reduced | Mar 2026 |
| 12 | Barclays Plc | 794,337 | $13M | Reduced | Mar 2026 |
| 13 | William Blair Investment Management, Llc | 739,790 | $13M | New | Mar 2026 |
| 14 | Principal Financial Group Inc | 476,718 | $12M | Reduced | Dec 2025 |
| 15 | Jpmorgan Chase & Co | 680,325 | $12M | Reduced | Mar 2026 |
| 16 | River Road Asset Management, Llc | 676,227 | $11M | Reduced | Mar 2026 |
| 17 | Aqr Capital Management Llc | 656,394 | $11M | Added | Mar 2026 |
| 18 | Jupiter Asset Management Ltd | 648,325 | $11M | Added | Mar 2026 |
| 19 | Kornitzer Capital Management Inc /ks | 427,031 | $11M | — | Dec 2025 |
| 20 | Nuveen, Llc | 587,763 | $10M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.33B
Enterprise Value
$2.02B
P/E (TTM)
40.12x
Forward P/E
22.31x
PEG Ratio
2.45x
P/B
4.31x
P/S
1.81x
P/FCF
12.17x
EV/EBITDA
20.15x
Shares Out
89.5M
Financials (TTM)
Revenue
$1.29B
Net Income
$58.5M
EBITDA
$100.4M
Free Cash Flow
$191.8M
Op Cash Flow
$210.2M
EPS Basic
$0.68
EPS Diluted
$0.65
EPS Forward
$1.17
Gross Margin
23.6%
Op Margin
6.6%
Net Margin
4.5%
Balance Sheet
Total Assets
$742.4M
Total Liab.
$226.4M
Total Equity
$516.0M
Cash
$310.1M
LT Debt
$0
Book Value/Sh
$6.05
Debt/Equity
0.05x
Current Ratio
2.73
Quick Ratio
2.73
Returns & Growth
ROE
2.4%
ROA
1.7%
ROIC
9.7%
Rev Growth YoY
+10.4%
EPS Growth YoY
+15.2%
Price Returns
2W
+11.8%
1M
+37.6%
3M
+44.5%
6M
-3.1%
12M
+18.9%
Technicals
52W High
$28.42
52W Low
$16.30
50d MA
$22.15
200d MA
$22.08
RSI (14)
54.90
ATR (14)
$0.84
Beta
0.99
Avg Volume
1.7M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$30.80
High
$35.00
Low
$28.00
Median
$30.00
Data updated apr 26, 2026 7:29pm
· Source: financialmodelingprep.com